John Miller

Chief Financial Officer

John Miller joined the NOW Diagnostics team as CFO in January 2024. John is a strategic financial professional whose career is marked by progressive roles, culminating as Chief Financial Officer at Acorn Influence. His tenure in various companies showcases a deep commitment to analyzing and optimizing financial performance and M&A leadership. John's strengths extend to comprehensive financial reporting, corporate governance, tax, banking, and legal strategy management, ensuring rigorous compliance and operational efficiency. His innovative approach to strategic planning, budgeting, and forecasting has consistently driven companies towards achieving their financial goals and scaling operations effectively. John is a certified public accountant and received his MBA from the University of Arkansas Sam Walton College of Business.

Visit LinkedIn

Check out what is making the news

Find out the latest in diagnostics testing.

FDA Clears NOWDiagnostics’ ADEXUSDx® hCG Test for Professional Use

Sophie Hefner

NOWDiagnostics, Inc. announced today that it has filed for expanded Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) of the ADEXUSDx® COVID-19 antibody test for point-of-care (POC)/CLIA waived testing. A prospective clinica...

NOWDiagnostics granted CE Mark for Rapid Syphilis Test

Sophie Hefner

On May 25, 2022, NOWDiagnostics was granted CE Mark for the ADEXUSDx® Syphilis rapid test. This treponemal assay requires only 1 drop of whole blood to perform and yields a laboratory quality result in just 15 minutes. The test has 100% sensitivity for all ...

NEW Automation Capacity Yields 2M Tests/Month

Sophie Hefner

To respond to increasing demand for diagnostic tests, NOWDiagnostics has invested in the development of a fully automated production system. The new automation can yield capacity of 2M ADEXUSDx® diagnostic tests per month and has the potential to reduce th...